Original Article

FORCED CHANGE IN RHEUMATOID ARTHRITIS TREATMENT DUE TO COVID-19 PANDEMIC: EFFECTS OF THE SWITCH FROM INTRAVENOUS TOCILIZUMAB TO SUBCUTANEOUS FORM

• Emrah Koç
• Mehmet Ali Aşık
• Didem Arslan Taş
• Süleyman Özbek

ANCA ASSOCIATED VASCULITIS: CLINICAL COURSE AND OUTCOME OF 44 PATIENTS FROM A SINGLE CENTER IN TURKEY

• Emrah Koç
• Mehmet Ali Aşık
• Esra Kayacan Erdoğan
• Didem Arslan
• Süleyman Özbek
• Hüseyin Turgut Elbek Özer

THE COURSE AND OUTCOMES OF COVID-19 IN PATIENTS WITH TAKAYASU ARTERITIS: CASE SERIES OF 15 PATIENTS FROM A TERTIARY SINGLE CENTER

• Gizem Sevik
• Seda Kutluğ Ağaçkıran
• Kerem Yiğit Abacar
• Alida Aliyeva
• Haner Direskeneli
• Fatma Alibaz Öner

RAPID3 SCORE CAN PREDICT DISEASE ACTIVITY IN PRIMARY SJÖGREN’S SYNDROME

• Mesude Seda Aydoğdu
• Burak Öz
• Zühal Ömercikoğlu
• Onur Çatak
• Nevzat Gözel
• Süleyman Çur
• Ahmet Karataş

Case Report And Literature Review

A CASE OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY ASSOCIATED WITH SYSTEMIC SCLEROSIS SUCCESSFULLY TREATED WITH RITUXIMAB

• Melike Keskin
• Rabia Deniz
• Cemal Bes

A TRIANGLE: RHEUMATOID ARTHRITIS, MYASTHENIA GRAVIS AND ANTI-TNF. GOOD NEWS OR BAD NEWS? LONG -TERM FOLLOW-UP: CASE REPORT AND REVIEW OF LITERATURE

• Emrah Koç
• Fatih Albayrak
• Hande Ece Öz
• Bünyamin Kısacık

Image Article

RICH SKIN MANIFESTATIONS IN DERMATOMYOSITIS

• Serkan Günaydın
• Ahmet Karataş